The face of the patent is not the ‘‘Whole Story’’: determining effective life of a pharmaceutical patent in the United States
-
Evergreening, patent challenges, and effective market life in pharmaceuticals
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s0167629612000057-mainDownload
-
To study the problems faced by innover from conception idea to filling patent in Indian pharmaceutical industry
Pharma Live, , Intellectual Property Rights, 0
1-s2-0-s2212567114002470-mainDownload
-
Court Cites Objects Of Invention In Claim Construction – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 24 FEBRUARY 2015POSTED IN CLAIM CONSTRUCTION;FEDERAL CIRCUIT DECISIONSPacing Technologies, LLC v. Garmin International, Inc. is one of...
-
Novo Nordisk rejects Baxter patent claim over Novoeight
Pharma Live, , Intellectual Property Rights, 0
COPENHAGEN, May 20 (Reuters) – Novo Nordisk said on Wednesday it rejected claims by U.S. rival Baxter International that...
-
Here’s a lucrative idea: Turn a drug into an orphan med, reap 6 months extra exclusivity – Courtesy (Fierce Pharma)
Pharma Live, , Intellectual Property Rights, 0
Would-be makers of rare disease meds, rejoice: A 6-month exclusivity extension, proposed last year in Congress, has returned. The 21st...
-
Amicus Briefs On Biosimilar Patent Litigation – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 23 APRIL 2015POSTED IN BIOSIMILARSAmgen has appealed the district court decision denying its motion for a...
-
Suven Life’s NCEs for neurodegenerative diseases receive European & Hong Kong patents – Courtesy(Pharmabiz.com)
Pharma Live, , Intellectual Property Rights, 0
Suven Life Sciences Ltd (Suven), a Hyderabad-based biopharmaceutical company focussed on discovering, developing and commercialising novel pharmaceutical products, has...
-
Louisiana Challenge’s AstraZeneca on Antitrust Claims for Asserting Invalid Drug Patents – Courtesy(PATENTLYO)
Pharma Live, , Intellectual Property Rights, 0
In March 2015, the state of Louisiana filed suit against AstraZeneca alleging antitrust violations based upon the company’s actions of...